Yasuda Mina, Tobino Kazunori, Harada Norihiro, Ooi Ryunosuke, Sueyasu Takuto, Nishizawa Saori, Munechika Miyuki, Yoshimine Kohei, Ko Yuki, Yoshimatsu Yuki, Tsuruno Kosuke, Ide Hiromi, Takahashi Kazuhisa
Department of Respiratory Medicine, Iizuka Hospital, 3-83 Yoshio Iizuka, Fukuoka, 820-8505, Japan.
Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
Allergy Asthma Clin Immunol. 2024 Feb 3;20(1):10. doi: 10.1186/s13223-024-00875-x.
Obstructive sleep apnea (OSA) occurs more commonly in asthma patients than in the general population because these conditions share some comorbidities. In Japan, the prevalence of OSA in the general population is reported to be approximately 20%; however, few reports have described the prevalence of OSA in asthma patients. Furthermore, the characteristics of Japanese patients with OSA and asthma are not clear.
Adult asthma patients were recruited from the outpatient departments of our institution between August 31, 2017, and March 31, 2019. In all included patients, the presence and severity of OSA were evaluated by the Epworth Sleepiness Scale (ESS) and a home sleep test (HST) using portable polysomnography (PSG). The rate of coexisting OSA in asthma patients and the characteristics of those patients according to the severity of OSA were investigated.
Fifty-three patients were included. OSA was detected in 36 (67.9%) patients (mild, n = 15; moderate, n = 14; and severe, n = 7). Patients with OSA had significantly higher body mass index, Brinkman index, apnea-hypopnea index (AHI), and 3% oxygen desaturation index (ODI) values in comparison to those without OSA, while the percentage of the predicted value of forced vital capacity (%FVC) and lowest SpO levels were significantly lower. As the severity of OSA increased, age, brain natriuretic peptide level, AHI, and 3%ODI increased, and in contrast, FVC, %FVC, forced expiratory volume in one second (FEV), percentage of the predicted value of FEV (%FEV), Epworth Sleepiness Scale (ESS), 3%ODI, and lowest SpO levels decreased. In particular, the fact that the ESS value was inversely correlated with the severity of OSA in our patients was different from the general characteristics of OSA. Moreover, the AHI value was negatively correlated with FVC, %FVC, FEV, and %FEV. BMI was the only independent factor for the presence of OSA, and for asthma severity (FEV1, % of predicted), there was a weak correlation with smoking history.
This is the first report to investigate the prevalence of OSA in Japanese asthma patients, using an HST. This study suggests that an HST should be performed in addition to the sleep interview for asthma patients with refractory disease, a low pulmonary function, advanced age, and high BMI because the more severe the OSA, the lower the ESS value may be.
阻塞性睡眠呼吸暂停(OSA)在哮喘患者中比在普通人群中更常见,因为这两种疾病有一些共同的合并症。在日本,据报道普通人群中OSA的患病率约为20%;然而,很少有报告描述哮喘患者中OSA的患病率。此外,日本OSA合并哮喘患者的特征尚不清楚。
2017年8月31日至2019年3月31日期间,从我院门诊招募成年哮喘患者。对所有纳入患者,通过爱泼华嗜睡量表(ESS)和使用便携式多导睡眠图(PSG)的家庭睡眠测试(HST)评估OSA的存在和严重程度。调查哮喘患者中OSA共存的发生率以及根据OSA严重程度的患者特征。
共纳入53例患者。36例(67.9%)患者检测到OSA(轻度,n = 15;中度,n = 14;重度,n = 7)。与无OSA的患者相比,OSA患者的体重指数、布林克曼指数、呼吸暂停低通气指数(AHI)和3%氧饱和度下降指数(ODI)值显著更高,而用力肺活量预测值百分比(%FVC)和最低SpO₂水平显著更低。随着OSA严重程度增加,年龄、脑钠肽水平、AHI和3%ODI升高,相反,FVC、%FVC、一秒用力呼气容积(FEV₁)、FEV₁预测值百分比(%FEV₁)、爱泼华嗜睡量表(ESS)、3%ODI和最低SpO₂水平下降。特别是,在我们的患者中ESS值与OSA严重程度呈负相关这一事实与OSA的一般特征不同。此外,AHI值与FVC、%FVC、FEV₁和%FEV₁呈负相关。BMI是OSA存在的唯一独立因素,对于哮喘严重程度(FEV₁,预测值百分比),与吸烟史有弱相关性。
这是第一项使用HST调查日本哮喘患者中OSA患病率的报告。本研究表明,对于难治性疾病、肺功能低下、年龄较大和BMI较高的哮喘患者,除了睡眠问诊外还应进行HST,因为OSA越严重,ESS值可能越低。